Efficacy of pharmaceutical care in dyslipidemia: systematic review

Detalhes bibliográficos
Autor(a) principal: Eizerik, Dauana Pitano
Data de Publicação: 2008
Outros Autores: Manfroi, Waldomiro Carlos
Tipo de documento: Artigo
Idioma: por
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/458
Resumo: Many patients undergoing treatment with lipid-lowering drugs do not reach their therapeutic goal for a number of reasons: nonadherence, polypharmacy, adverse reactions. Pharmaceutical care aims at increasing therapeutic adherence, decreasing toxicity and improving outcomes, preventing and solving drug-related problems. We performed a systematic review of the literature to evaluate pharmaceutical care efficacy in the management of dyslipidemia. The MEDLINE database (1966 to May 2006) was searched for articles, and the Cochrane Library for clinical trials. Inclusion criteria were studies consisting of randomized clinical trials evaluating pharmaceutical care efficacy in dyslipidemia, with language restriction. MEDLINE search yielded six articles. Search in the Cochrane Library did not add any new clinical trial. All selected articles had positive results of pharmaceutical intervention in dyslipidemia. Cardiovascular diseases, especially dyslipidemia, have characteristics suggesting need of treatment guidance and monitoring. According to reviewed articles, pharmaceutical care contributes to better treatment of dyslipidemia
id UFRGS-20_6468408406427cddedc08fdd63fa484a
oai_identifier_str oai:seer.ufrgs.br:article/458
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling Efficacy of pharmaceutical care in dyslipidemia: systematic reviewEficácia da Atenção Farmacêutica em Dislipidemia: Revisão SistemáticaFarmacologia ClínicaDislipidemiaFarmacologia ClínicaMany patients undergoing treatment with lipid-lowering drugs do not reach their therapeutic goal for a number of reasons: nonadherence, polypharmacy, adverse reactions. Pharmaceutical care aims at increasing therapeutic adherence, decreasing toxicity and improving outcomes, preventing and solving drug-related problems. We performed a systematic review of the literature to evaluate pharmaceutical care efficacy in the management of dyslipidemia. The MEDLINE database (1966 to May 2006) was searched for articles, and the Cochrane Library for clinical trials. Inclusion criteria were studies consisting of randomized clinical trials evaluating pharmaceutical care efficacy in dyslipidemia, with language restriction. MEDLINE search yielded six articles. Search in the Cochrane Library did not add any new clinical trial. All selected articles had positive results of pharmaceutical intervention in dyslipidemia. Cardiovascular diseases, especially dyslipidemia, have characteristics suggesting need of treatment guidance and monitoring. According to reviewed articles, pharmaceutical care contributes to better treatment of dyslipidemiaGrande parte dos pacientes em tratamento com hipolipemiantes não atinge a meta terapêutica por diversas razões: falta de adesão, polifarmácia, reações adversas. A atenção farmacêutica tem como metas aumentar a adesão terapêutica, diminuir a toxicidade e otimizar resultados, prevenir e solucionar problemas relacionados a medicamentos (PRMs). O objetivo desse trabalho foi de revisar a literatura de forma sistemática para avaliar a eficácia da atenção farmacêutica no manejo da dislipidemia. Foram pesquisados artigos na base de dados MEDLINE (1966 – maio de 2006) e no banco de ensaios clínicos da biblioteca Cochrane. Foram incluídos estudos com delineamento de ensaios clínicos randomizados (ECR) que avaliassem a eficácia da atenção farmacêutica em dislipidemia com limitação de idiomas. A busca resultou em seis artigos selecionados no MEDLINE. A pesquisa na base de ensaios clínicos da Cochrane não acrescentou artigos diferentes. Todos os artigos analisados demonstraram resultados positivos da intervenção farmacêutica em dislipidemia. As doenças cardiovasculares, em especial a dislipidemia, possuem características que necessitam de orientação e monitorização do seu tratamento. De acordo com os artigos revisados, a atenção farmacêutica contribui para melhor tratamento da dislipidemia.HCPA/FAMED/UFRGS2008-04-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliados por Paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/458Clinical & Biomedical Research; Vol. 28 No. 1 (2008): Revista HCPAClinical and Biomedical Research; v. 28 n. 1 (2008): Revista HCPA2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/458/2196Eizerik, Dauana PitanoManfroi, Waldomiro Carlosinfo:eu-repo/semantics/openAccess2020-01-16T16:15:43Zoai:seer.ufrgs.br:article/458Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2020-01-16T16:15:43Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv Efficacy of pharmaceutical care in dyslipidemia: systematic review
Eficácia da Atenção Farmacêutica em Dislipidemia: Revisão Sistemática
title Efficacy of pharmaceutical care in dyslipidemia: systematic review
spellingShingle Efficacy of pharmaceutical care in dyslipidemia: systematic review
Eizerik, Dauana Pitano
Farmacologia Clínica
Dislipidemia
Farmacologia Clínica
title_short Efficacy of pharmaceutical care in dyslipidemia: systematic review
title_full Efficacy of pharmaceutical care in dyslipidemia: systematic review
title_fullStr Efficacy of pharmaceutical care in dyslipidemia: systematic review
title_full_unstemmed Efficacy of pharmaceutical care in dyslipidemia: systematic review
title_sort Efficacy of pharmaceutical care in dyslipidemia: systematic review
author Eizerik, Dauana Pitano
author_facet Eizerik, Dauana Pitano
Manfroi, Waldomiro Carlos
author_role author
author2 Manfroi, Waldomiro Carlos
author2_role author
dc.contributor.author.fl_str_mv Eizerik, Dauana Pitano
Manfroi, Waldomiro Carlos
dc.subject.por.fl_str_mv Farmacologia Clínica
Dislipidemia
Farmacologia Clínica
topic Farmacologia Clínica
Dislipidemia
Farmacologia Clínica
description Many patients undergoing treatment with lipid-lowering drugs do not reach their therapeutic goal for a number of reasons: nonadherence, polypharmacy, adverse reactions. Pharmaceutical care aims at increasing therapeutic adherence, decreasing toxicity and improving outcomes, preventing and solving drug-related problems. We performed a systematic review of the literature to evaluate pharmaceutical care efficacy in the management of dyslipidemia. The MEDLINE database (1966 to May 2006) was searched for articles, and the Cochrane Library for clinical trials. Inclusion criteria were studies consisting of randomized clinical trials evaluating pharmaceutical care efficacy in dyslipidemia, with language restriction. MEDLINE search yielded six articles. Search in the Cochrane Library did not add any new clinical trial. All selected articles had positive results of pharmaceutical intervention in dyslipidemia. Cardiovascular diseases, especially dyslipidemia, have characteristics suggesting need of treatment guidance and monitoring. According to reviewed articles, pharmaceutical care contributes to better treatment of dyslipidemia
publishDate 2008
dc.date.none.fl_str_mv 2008-04-15
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
Avaliados por Pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/458
url https://seer.ufrgs.br/index.php/hcpa/article/view/458
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/458/2196
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 28 No. 1 (2008): Revista HCPA
Clinical and Biomedical Research; v. 28 n. 1 (2008): Revista HCPA
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1799767051161567232

Registros relacionados